Article Details

Monte Rosa snags $95M to speed lead 'molecular glue' treatment into the clinic

Retrieved on: 2021-03-12 15:24:45

Tags for this article:

Click the tags to see associated articles and topics

Monte Rosa snags $95M to speed lead 'molecular glue' treatment into the clinic. View article details on hiswai:

Excerpt

... series C comes from more than a dozen backers, including founding investor Versant Ventures, Aisling Capital, GV and New Enterprise Associates.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo